
About IHTC
At the Indiana Hemophilia & Thrombosis Center (IHTC), we offer a future where people with rare blood disorders flourish. Our experts provide the highest quality comprehensive services and holistic care to patients with bleeding, clotting and other hematologic disorders, and to their families.
What You Will Do
As Patient Engagement Manager (PEM), you will be responsible for managing IHI relationships with patients, prescribing providers, health systems, manufacturer partners, and internal specialty pharmacy teams. This role ensures an exceptional end‑to‑end experience across complex therapy access, onboarding, fulfillment, adherence, and ongoing clinical support for specialty medications. The PEM acts as a strategic coordinator between pharmacy operations, clinical teams, reimbursement functions, and external stakeholders in managing complex cases in order to minimize access delays, improving patient outcomes, and maximize satisfaction and retention, while ensuring strict compliance with regulatory and accreditation standards.
The Opportunity
Requirements
This position is open to residents of the State of Indiana, and requires routine presence at our Center in Indianapolis, IN. Frequency of on-site presence is dependent upon role and department needs.
Benefits
Why join our team?
The IHTC is a not-for-profit program based in Indianapolis and offers a competitive salary and benefit package.
The IHTC is the only federally designated comprehensive hemophilia program in Indiana and serves the entire state through services available in Indianapolis and at outreach clinics.
The IHTC is a leader in hemophilia care, education and clinical research and has a dedicated on-site multidisciplinary staff to ensure availability of a wide range of required services.
The IHTC participates in national and international clinical research, including new infusion products and therapies, investigation of long-term outcomes, and the impact of associated conditions. The IHTC research program provides patients access to new therapies, and an opportunity to improve care. Our center has more than 50 clinical research projects involving bleeding disorders, sickle cell disease, thrombosis and more.
The Indiana Hemophilia and Thrombosis Center is an Equal Opportunity Employer.

Innovative Hematology, Inc. treats blood disorders—from common to rare—every day. Innovative Hematology is a certified medical home recognized for excellence in comprehensive patient-centered health care.
Innovative Hematology is home to the Indiana Hemophilia and Thrombosis Center (also known as the IHTC, a 501(c)3), one of the nation’s top federally recognized hemophilia treatment centers, where we treat hemophilia, von Willebrand disease, and other rare bleeding and clotting conditions. Innovative Hematology also treats sickle cell disease, thalassemia, and other blood disorders such as HHT and nutritional anemias.
Innovative Hematology is both nationally and internationally distinguished as a Center of Excellence for its leadership in blood disorder patient care, education and research.